21 – 30 of 8088
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Spatial TCR clonality and clonal expansion in the in situ microenvironment of non-small cell lung cancer
- Contribution to journal › Article
-
Mark
Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer : A study protocol of ARIADNE
- Contribution to journal › Article
-
Mark
Identification of a small molecule targeting EPLIN as a novel strategy for the treatment of pediatric neuroblastoma and medulloblastoma
- Contribution to journal › Article
-
Mark
Prospective evaluation of surgical treatment of liver metastasizing pancreatic cancer - ScanPan study protocol
- Contribution to journal › Article
-
Mark
Understanding the role of obesity in endocrine therapy for postmenopausal breast cancer : significance of the BIG 1–98 and ATAC trial data
- Contribution to journal › Scientific review
-
Mark
Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in patients with newly diagnosed pancreatic cancer
- Contribution to journal › Article
-
Mark
Serine-arginine protein kinase 1 (SRPK1) is under-expressed in mucinous colorectal cancer, and may mediate resistance to oxaliplatin
- Contribution to journal › Article
-
Mark
Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH) : a randomised, open-label, phase 2/3 superiority trial
(2025) In The Lancet
- Contribution to journal › Article
-
Mark
Janus kinase 1 inhibitors for treating immune checkpoint inhibitor-induced enterocolitis - report of two filgotinib-treated cases and literature review
- Contribution to journal › Scientific review
-
Mark
Targeted ferroptosis induction enhances chemotherapy efficacy in chemoresistant neuroblastoma
- Contribution to journal › Article
